Financhill
Buy
81

CPAI Quote, Financials, Valuation and Earnings

Last price:
$39.95
Seasonality move :
6.15%
Day range:
$39.60 - $39.97
52-week range:
$28.48 - $40.35
Dividend yield:
0.35%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
7.2K
Avg. volume:
16.1K
1-year change:
9.04%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CPAI
Counterpoint Quantitative Equity ETF
-- -- -- -- --
BMVP
Invesco Bloomberg MVP Multi-Factor ETF
-- -- -- -- --
SIXL
ETC 6 Meridian Low Beta Equity Strategy ETF
-- -- -- -- --
SIZE
iShares MSCI USA Size Factor ETF
-- -- -- -- --
SOVF
Sovereign's Capital Flourish Fund
-- -- -- -- --
SRHQ
SRH US Quality GARP ETF
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CPAI
Counterpoint Quantitative Equity ETF
$39.92 -- -- -- $0.14 0.35% --
BMVP
Invesco Bloomberg MVP Multi-Factor ETF
$49.10 -- -- -- $0.21 1.65% --
SIXL
ETC 6 Meridian Low Beta Equity Strategy ETF
$36.60 -- -- -- $0.07 2.14% --
SIZE
iShares MSCI USA Size Factor ETF
$162.53 -- -- -- $0.63 1.44% --
SOVF
Sovereign's Capital Flourish Fund
$28.68 -- -- -- $0.09 0.32% --
SRHQ
SRH US Quality GARP ETF
$39.30 -- -- -- $0.08 0.69% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CPAI
Counterpoint Quantitative Equity ETF
-- 1.281 -- --
BMVP
Invesco Bloomberg MVP Multi-Factor ETF
-- 0.545 -- --
SIXL
ETC 6 Meridian Low Beta Equity Strategy ETF
-- 0.139 -- --
SIZE
iShares MSCI USA Size Factor ETF
-- 0.865 -- --
SOVF
Sovereign's Capital Flourish Fund
-- 0.865 -- --
SRHQ
SRH US Quality GARP ETF
-- 0.775 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CPAI
Counterpoint Quantitative Equity ETF
-- -- -- -- -- --
BMVP
Invesco Bloomberg MVP Multi-Factor ETF
-- -- -- -- -- --
SIXL
ETC 6 Meridian Low Beta Equity Strategy ETF
-- -- -- -- -- --
SIZE
iShares MSCI USA Size Factor ETF
-- -- -- -- -- --
SOVF
Sovereign's Capital Flourish Fund
-- -- -- -- -- --
SRHQ
SRH US Quality GARP ETF
-- -- -- -- -- --

Counterpoint Quantitative Equity ETF vs. Competitors

  • Which has Higher Returns CPAI or BMVP?

    Invesco Bloomberg MVP Multi-Factor ETF has a net margin of -- compared to Counterpoint Quantitative Equity ETF's net margin of --. Counterpoint Quantitative Equity ETF's return on equity of -- beat Invesco Bloomberg MVP Multi-Factor ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- --
    BMVP
    Invesco Bloomberg MVP Multi-Factor ETF
    -- -- --
  • What do Analysts Say About CPAI or BMVP?

    Counterpoint Quantitative Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Bloomberg MVP Multi-Factor ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Counterpoint Quantitative Equity ETF has higher upside potential than Invesco Bloomberg MVP Multi-Factor ETF, analysts believe Counterpoint Quantitative Equity ETF is more attractive than Invesco Bloomberg MVP Multi-Factor ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    CPAI
    Counterpoint Quantitative Equity ETF
    0 0 0
    BMVP
    Invesco Bloomberg MVP Multi-Factor ETF
    0 0 0
  • Is CPAI or BMVP More Risky?

    Counterpoint Quantitative Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Bloomberg MVP Multi-Factor ETF has a beta of 0.949, suggesting its less volatile than the S&P 500 by 5.089%.

  • Which is a Better Dividend Stock CPAI or BMVP?

    Counterpoint Quantitative Equity ETF has a quarterly dividend of $0.14 per share corresponding to a yield of 0.35%. Invesco Bloomberg MVP Multi-Factor ETF offers a yield of 1.65% to investors and pays a quarterly dividend of $0.21 per share. Counterpoint Quantitative Equity ETF pays -- of its earnings as a dividend. Invesco Bloomberg MVP Multi-Factor ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CPAI or BMVP?

    Counterpoint Quantitative Equity ETF quarterly revenues are --, which are smaller than Invesco Bloomberg MVP Multi-Factor ETF quarterly revenues of --. Counterpoint Quantitative Equity ETF's net income of -- is lower than Invesco Bloomberg MVP Multi-Factor ETF's net income of --. Notably, Counterpoint Quantitative Equity ETF's price-to-earnings ratio is -- while Invesco Bloomberg MVP Multi-Factor ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Counterpoint Quantitative Equity ETF is -- versus -- for Invesco Bloomberg MVP Multi-Factor ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- -- --
    BMVP
    Invesco Bloomberg MVP Multi-Factor ETF
    -- -- -- --
  • Which has Higher Returns CPAI or SIXL?

    ETC 6 Meridian Low Beta Equity Strategy ETF has a net margin of -- compared to Counterpoint Quantitative Equity ETF's net margin of --. Counterpoint Quantitative Equity ETF's return on equity of -- beat ETC 6 Meridian Low Beta Equity Strategy ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- --
    SIXL
    ETC 6 Meridian Low Beta Equity Strategy ETF
    -- -- --
  • What do Analysts Say About CPAI or SIXL?

    Counterpoint Quantitative Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ETC 6 Meridian Low Beta Equity Strategy ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Counterpoint Quantitative Equity ETF has higher upside potential than ETC 6 Meridian Low Beta Equity Strategy ETF, analysts believe Counterpoint Quantitative Equity ETF is more attractive than ETC 6 Meridian Low Beta Equity Strategy ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    CPAI
    Counterpoint Quantitative Equity ETF
    0 0 0
    SIXL
    ETC 6 Meridian Low Beta Equity Strategy ETF
    0 0 0
  • Is CPAI or SIXL More Risky?

    Counterpoint Quantitative Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ETC 6 Meridian Low Beta Equity Strategy ETF has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.268%.

  • Which is a Better Dividend Stock CPAI or SIXL?

    Counterpoint Quantitative Equity ETF has a quarterly dividend of $0.14 per share corresponding to a yield of 0.35%. ETC 6 Meridian Low Beta Equity Strategy ETF offers a yield of 2.14% to investors and pays a quarterly dividend of $0.07 per share. Counterpoint Quantitative Equity ETF pays -- of its earnings as a dividend. ETC 6 Meridian Low Beta Equity Strategy ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CPAI or SIXL?

    Counterpoint Quantitative Equity ETF quarterly revenues are --, which are smaller than ETC 6 Meridian Low Beta Equity Strategy ETF quarterly revenues of --. Counterpoint Quantitative Equity ETF's net income of -- is lower than ETC 6 Meridian Low Beta Equity Strategy ETF's net income of --. Notably, Counterpoint Quantitative Equity ETF's price-to-earnings ratio is -- while ETC 6 Meridian Low Beta Equity Strategy ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Counterpoint Quantitative Equity ETF is -- versus -- for ETC 6 Meridian Low Beta Equity Strategy ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- -- --
    SIXL
    ETC 6 Meridian Low Beta Equity Strategy ETF
    -- -- -- --
  • Which has Higher Returns CPAI or SIZE?

    iShares MSCI USA Size Factor ETF has a net margin of -- compared to Counterpoint Quantitative Equity ETF's net margin of --. Counterpoint Quantitative Equity ETF's return on equity of -- beat iShares MSCI USA Size Factor ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- --
    SIZE
    iShares MSCI USA Size Factor ETF
    -- -- --
  • What do Analysts Say About CPAI or SIZE?

    Counterpoint Quantitative Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares MSCI USA Size Factor ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Counterpoint Quantitative Equity ETF has higher upside potential than iShares MSCI USA Size Factor ETF, analysts believe Counterpoint Quantitative Equity ETF is more attractive than iShares MSCI USA Size Factor ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    CPAI
    Counterpoint Quantitative Equity ETF
    0 0 0
    SIZE
    iShares MSCI USA Size Factor ETF
    0 0 0
  • Is CPAI or SIZE More Risky?

    Counterpoint Quantitative Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares MSCI USA Size Factor ETF has a beta of 0.999, suggesting its less volatile than the S&P 500 by 0.149%.

  • Which is a Better Dividend Stock CPAI or SIZE?

    Counterpoint Quantitative Equity ETF has a quarterly dividend of $0.14 per share corresponding to a yield of 0.35%. iShares MSCI USA Size Factor ETF offers a yield of 1.44% to investors and pays a quarterly dividend of $0.63 per share. Counterpoint Quantitative Equity ETF pays -- of its earnings as a dividend. iShares MSCI USA Size Factor ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CPAI or SIZE?

    Counterpoint Quantitative Equity ETF quarterly revenues are --, which are smaller than iShares MSCI USA Size Factor ETF quarterly revenues of --. Counterpoint Quantitative Equity ETF's net income of -- is lower than iShares MSCI USA Size Factor ETF's net income of --. Notably, Counterpoint Quantitative Equity ETF's price-to-earnings ratio is -- while iShares MSCI USA Size Factor ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Counterpoint Quantitative Equity ETF is -- versus -- for iShares MSCI USA Size Factor ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- -- --
    SIZE
    iShares MSCI USA Size Factor ETF
    -- -- -- --
  • Which has Higher Returns CPAI or SOVF?

    Sovereign's Capital Flourish Fund has a net margin of -- compared to Counterpoint Quantitative Equity ETF's net margin of --. Counterpoint Quantitative Equity ETF's return on equity of -- beat Sovereign's Capital Flourish Fund's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- --
    SOVF
    Sovereign's Capital Flourish Fund
    -- -- --
  • What do Analysts Say About CPAI or SOVF?

    Counterpoint Quantitative Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Sovereign's Capital Flourish Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Counterpoint Quantitative Equity ETF has higher upside potential than Sovereign's Capital Flourish Fund, analysts believe Counterpoint Quantitative Equity ETF is more attractive than Sovereign's Capital Flourish Fund.

    Company Buy Ratings Hold Ratings Sell Ratings
    CPAI
    Counterpoint Quantitative Equity ETF
    0 0 0
    SOVF
    Sovereign's Capital Flourish Fund
    0 0 0
  • Is CPAI or SOVF More Risky?

    Counterpoint Quantitative Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sovereign's Capital Flourish Fund has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CPAI or SOVF?

    Counterpoint Quantitative Equity ETF has a quarterly dividend of $0.14 per share corresponding to a yield of 0.35%. Sovereign's Capital Flourish Fund offers a yield of 0.32% to investors and pays a quarterly dividend of $0.09 per share. Counterpoint Quantitative Equity ETF pays -- of its earnings as a dividend. Sovereign's Capital Flourish Fund pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CPAI or SOVF?

    Counterpoint Quantitative Equity ETF quarterly revenues are --, which are smaller than Sovereign's Capital Flourish Fund quarterly revenues of --. Counterpoint Quantitative Equity ETF's net income of -- is lower than Sovereign's Capital Flourish Fund's net income of --. Notably, Counterpoint Quantitative Equity ETF's price-to-earnings ratio is -- while Sovereign's Capital Flourish Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Counterpoint Quantitative Equity ETF is -- versus -- for Sovereign's Capital Flourish Fund. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- -- --
    SOVF
    Sovereign's Capital Flourish Fund
    -- -- -- --
  • Which has Higher Returns CPAI or SRHQ?

    SRH US Quality GARP ETF has a net margin of -- compared to Counterpoint Quantitative Equity ETF's net margin of --. Counterpoint Quantitative Equity ETF's return on equity of -- beat SRH US Quality GARP ETF's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- --
    SRHQ
    SRH US Quality GARP ETF
    -- -- --
  • What do Analysts Say About CPAI or SRHQ?

    Counterpoint Quantitative Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SRH US Quality GARP ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Counterpoint Quantitative Equity ETF has higher upside potential than SRH US Quality GARP ETF, analysts believe Counterpoint Quantitative Equity ETF is more attractive than SRH US Quality GARP ETF.

    Company Buy Ratings Hold Ratings Sell Ratings
    CPAI
    Counterpoint Quantitative Equity ETF
    0 0 0
    SRHQ
    SRH US Quality GARP ETF
    0 0 0
  • Is CPAI or SRHQ More Risky?

    Counterpoint Quantitative Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison SRH US Quality GARP ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CPAI or SRHQ?

    Counterpoint Quantitative Equity ETF has a quarterly dividend of $0.14 per share corresponding to a yield of 0.35%. SRH US Quality GARP ETF offers a yield of 0.69% to investors and pays a quarterly dividend of $0.08 per share. Counterpoint Quantitative Equity ETF pays -- of its earnings as a dividend. SRH US Quality GARP ETF pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CPAI or SRHQ?

    Counterpoint Quantitative Equity ETF quarterly revenues are --, which are smaller than SRH US Quality GARP ETF quarterly revenues of --. Counterpoint Quantitative Equity ETF's net income of -- is lower than SRH US Quality GARP ETF's net income of --. Notably, Counterpoint Quantitative Equity ETF's price-to-earnings ratio is -- while SRH US Quality GARP ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Counterpoint Quantitative Equity ETF is -- versus -- for SRH US Quality GARP ETF. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CPAI
    Counterpoint Quantitative Equity ETF
    -- -- -- --
    SRHQ
    SRH US Quality GARP ETF
    -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 176.02% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is up 0.38% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 1.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock